Cell cycle regulatory proteins are important candidates for therapeutic tumour suppressors. Adenovirus vectors were constructed to overexpress cyclin kinase inhibitors p16 INK4A , p18
Introduction
Cell cycle regulatory proteins play a critical role in both normal cell growth and tumorigenesis, and the cyclin dependent kinases (CDKs) are the principle regulators of cell cycle progression (reviewed in Grana and Reddy, 1995; Hunter and Pines, 1994; Kamb, 1995; Sherr, 1994) , and thus are important candidates for therapeutic tumour suppressors. The CDKs, which are responsible for the phosphorylation of the retinoblastoma protein (pRb) and pRb related proteins, are in turn regulated by changes in cyclin levels, phosphorylation and the presence of cyclin kinase inhibitors (CKIs) (Morgan, 1995; Sellers and Kaelin, 1997) . Hypophosphorylated pRb binds and represses the E2F family of transcription factors, but once phosphorylated, pRb releases E2F, allowing it to activate genes required for S phase entry. Recent evidence suggests that the regulated inhibition of the CDKs is central to cellular responses such as dierentiation, senescence, DNA damage and perhaps even apoptosis Grana and Reddy, 1995; Sherr, 1996) .
Two classes of CKIs are present within mammalian cells (reviewed in Harper and Elledge, 1996; Sherr and Roberts, 1995; Xiong, 1996) . One class, the p21 family, consists of p21
, p27 KIP1 and p57 KIP2 which are general inhibitors of the G 1 S CDKs. Homology between family members is limited to a conserved amino-terminal 60-residue domain responsible for kinase binding and inhibition. The second class of CKIs, the INK4 (Inhibitor of CDK4) family is a group of ankyrin repeat proteins whose members p16 INK4a , p15 INK4b , p18 INK4c and p19 INK4d are speci®c inhibitors of cyclin D1/CDK4 or CDK6 complexes. Why there are so many CKIs and the roles of each of the CKIs in cell cycle regulation, dierentiation and tumorigenicity is actively being studied.
The ®rst CKI identi®ed was p21 which is induced by the p53 tumour suppressor upon DNA damage (Gartel et al., 1996) . In cellular dierentiation, p53-independent induction of p21 has been observed as an immediate early response to a variety of physiological and chemical stimuli (Jiang et al., 1994; Steinman et al., 1994) . In addition, p21 expression has been shown to have a protective eect against apoptosis induced by p53 as well as other agents Lu et al., 1998) . However, despite extensive searches, very few tumours have been shown to have mutations in their p21 genes , and mice null for p21 develop normally with no increased incidence of neoplasia (Deng et al., 1995) . Another CKI in the p21 family is p27, which mediates growth arrest induced by transforming growth factor b, contact inhibition, or serum deprivation, and is thought to play a critical role in negative regulation of cell division in vivo (Sherr, 1996) . The phenotype of mice null for the p27 gene includes increased body size, female sterility and a high incidence of spontaneous pituitary tumours (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Recently, high level expression of p27 from adenovirus (Ad) vectors has been shown to induce apoptosis in tumour cell lines Wang et al., 1997) .
The INK4 proteins are expressed in distinct tissue speci®c patterns which may explain why there is an abundance of these proteins with similar functions (Sherr, 1996) . The best characterized member of the INK4 family is p16. Mutations within the p16 gene and loss of p16 expression are frequent events observed in both tumour cell lines and in various carcinomas (Sellers and Kaelin, 1997; Sherr, 1996) . Moreover, transgenic mice with targeted p16 mutations develop spontaneous tumours at an early age (Serrano et al., 1996) . The p18 and p19 CKIs, as yet, have not been as well characterized. Cells of the myeloid lineage frequently express p18 and p19 (Schwaller et al., 1997) , and p18 is thought to play a pivotal role in terminal dierentiation of late-stage B cells to plasma cells (Morse et al., 1997) .
Because of their ability to inhibit the phosphorylation and consequent inactivation of pRb by cyclin/ cyclin dependent kinase complexes and their ability thereby to induce a G 1 growth arrest, the various CKIs are potentially therapeutic tumour suppressors. Recombinant adenovirus vectors have been used to examine and compare the eects of p53, p21, p27 and p16 expression on growth arrest and apoptosis in vitro (Craig et al., 1997; Katayose et al., 1998; Terada et al., 1997) . Although several reports have described viral-mediated gene therapy approaches to deliver p16 and p21 genes to a number of dierent tumour models (Eastham et al., 1995; Gotoh et al., 1997; Jin et al., 1995; Ohno et al., 1997; Yang et al., 1995) , little work has been done to comprehensively compare the ecacies of the dierent CKIs to inhibit cell growth and induce tumour regressions. In this present study, we examined and compared the ability of adenovirus vectors expressing CKIs p16, p18, p19, p21 and p27 to block proliferation of various cell lines in vitro, to inhibit tumorigenicity of primary polyoma virus middle T antigen (PyMidT) transformed cells infected ex vivo, and to inhibit growth of tumours infected in vivo.
Results

Ad vectors direct the expression of cyclin kinase inhibitors
Several Ad vectors were constructed to express dierent human cyclin kinase inhibitors, with the expression cassette replacing E1 in an E3 deleted background. The general structure of the vectors is diagrammed in Figure 1a . These vectors replicate in E1-complementing 293 cells but are defective for replication in other cells. Transgene expression is under the control of the murine cytomegalovirus MCMV IE promoter and the SV40 polyadenylation signal. Previously it was found that the MCMV IE promoter gave higher expression levels in murine cells when compared with those obtained with the HCMV IE promoter, and transgene expression directed by the two promoters was comparable in human cells (Addison et al., 1997) . These Ad vectors directed ecient expression of the dierent transgenes in a variety of human and mouse cell lines. Figure 1b shows the results of Western blots of lysates from infected A549, MT1A2, HeLa, SKOV-3 and MRC-5 cells, probed with antibodies against human p16, p21 and p27 respectively. In lysates from all the cell lines tested that had been infected with AdMH4p16, a 16 kD protein band was observed that was absent in lysates from mock and control virus infected cells. When probing for human p27, excellent p27 expression was observed in all cell lines infected with AdMH4p27. Endogenous p21 protein was observed in both mockand control virus-infected A549, HeLa and MRC-5 cells, but upon transduction with AdMH4p21, signi®cantly higher levels were observed in A549 and HeLa cell lysates. In contrast, with MT1A2 and SKOV-3 cells, p21 protein was detected only in lysates from cells transduced with AdMH4p21 and not in lysates from mock-or control virus-infected cells (Figure 1b) . Since cellular p53 is capable of inducing endogenous p21 expression (Gartel et al., 1996) , we also examined whether Adp53wt, the Ad vector Figure 1 Structure and characterization of Ad vectors expressing CKIs (a) General structure of the E1, E3 deleted Ad genome (AdBHGD1,3) showing inverted terminal repeats (ITR), packaging signal (C), and the E1 (DE1) and E3 (DE3) deletions, with an expression cassette consisting of the MCMV promoter, CKI coding sequence (shaded box) and SV40 poly A termination signal inserted into the E1 region. (a) Western blot showing Advector driven expression of p16, p27 and p21. A549, MT1A2, HeLa, SKOV-3, and MRC-5 cells were mock (m), AdBHGD1,3 (c), AdMH4p16 (p16), AdMH4p21 (p21), AdMH4p27 (p27) or Adp53wt (p53) -infected at a m.o.i. of 100 for 48 h, after which cell lysates were prepared and protein from equivalent cell numbers analysed by Western blotting as outlined under the Materials and methods. Blots were probed with rabbit antihuman polyclonal p16 antibody (Clontech), mouse monoclonal anti-human WAF-1 antibody (Calbiochem) or mouse monoclonal anti-human p27 antibody (Calbiochem) as indicated. (c) Metabolic labelling of expressed proteins. 293 cells were infected at a m.o.i. of 100 for 8 h, and then cellular proteins were labelled with 35 S-methionine/cysteine overnight as described under Materials and methods. Cell lysates were prepared and protein from equal cell numbers analysed by SDS ± PAGE and phorphorimaging. Proteins from mock (m), AdBHGD1,3 (c), AdMH4p16 (p16), AdMH4p18 (p18), AdMH4p19 (p19), AdMH4p21 (p21), and AdMH4p27 (p27)-infected cells are shown. Protein standards migrating at 220, 97.4, 66, 46, 30, 21 .5 and 14.3 kD are indicated expressing human p53, was able to induce p21 expression within these dierent cell lines. In lysates from A549, HeLa and MRC-5 cells, the levels of p21 observed were similar between control-and Adp53wt-transduced cells, whereas in lysates from Adp53wt-infected MT1A2 cells, a very faint p21 signal was observed. In p53-null SKOV-3 cells, Adp53wt was able to induce the expression of endogenous p21.
Because antibodies against human p18 or human p19 were not available for Western blot or immunoprecipitation analysis, we used 35 S-methionine labelling and gel electrophoresis to determine whether the corresponding Ad vectors were directing the ecient expression of these proteins. 293 cells infected with the Ad vectors were labelled with 35 S-methionine/cysteine 8 to 24 h postinfection, and the labelled proteins analysed by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE). Protein bands consistent with expression of p16, p18, p19 and p27 were observed (Figure 1c) . Moreover, these putative CKIs represented the major species labelled at this time period, consistent with the results of Western analysis. It was dicult to detect p21 expression which might re¯ect instability during productive viral infection within 293 cells. When we examined expression in other cell lines, the background of labelled host proteins was much higher, although it was possible to detect proteins migrating at the appropriate sizes for p18 and p19 from lysates of cells infected with the dierent Ads (data not shown). These results demonstrate that these Ad vectors can direct ecient expression of all the CKI cDNAs cloned in Ad5.
Inhibition of tumour cell growth by exogenous CKIs in vitro
To study the eects of Ad-vector driven expression of CKIs on cell growth, A549 and MT1A2 cells were left untreated (mock), or were infected with control virus or the Ad viruses expressing the various CKIs, at a multiplicity of infection (m.o.i.) of 100, and the number of viable cells was measured over a period of 4 ± 6 days ( Figure 2a and b) . There was a modest inhibition of cell growth caused by infection with control virus, AdBHGD1,3. However, the CKIs gave a very pronounced inhibition of growth. Within 1 day postinfection for transduced A549 cells and 2 days postinfection with MT1A2 cells, a block in cell growth was observed in cells expressing the dierent CKIs with few cells staining positive with Trypan blue, indicating the exogenous CKIs were having a cytostatic eect on growth. More dramatic eects were observed in the human lung carcinoma A549 cells compared to the PyMidT-transformed mouse MT1A2 cells (compare Figure 2a with b) , although each of the human CKIs were functional in the mouse cell line and induced a growth arrest, indicating that the action of human CKIs is not restricted to human cells. Mock and control virus infected cells grew until con¯uent (day 4) and then entered a growth arrest following which signi®cant numbers of Trypan blue-staining cells were observed, indicative of cell death, accounting for the decline in cell number, which was especially apparent in con¯uent MT1A2 cultures. By 3 days post-infection, cells staining positive with Trypan blue were observed in the cultures infected with the various CKIexpressing Ad vectors even though the monolayers were not con¯uent, and this cell death accounted for the over-all reduction in cell number that was observed during the remainder of the experiment. Cell death was greatest in MT1A2 and A549 cells transduced with Ad vectors expressing p16, p18 and p27 ( Figure 2 and Table 2 ), whereas p19 and p21 expression had a more cytostatic eect on cell proliferation. The eects of Ad vector driven p53 expression were also examined since its growth inhibitory properties have been well characterized and since p53-expressing Ads have been shown to inhibit DNA synthesis and promote apoptosis (Bacchetti and Graham, 1993; Cox, 1997; Putzer et al., 1998) . Interestingly, while infection with Adp53wt had an antiproliferative eect in A549 cells, which is most likely due to induction of endogenous p21 expression (Figure 1b) , in mouse MT1A2 cells the eects of human p53 over-expression were more modest.
To con®rm that over-expression of the various CKIs inhibited DNA synthesis, a variety of human and murine cell lines were infected with the Ad vectors at a m.o.i. of 100, and after 2 days, DNA replication was measured by [ (Figure 3d ). MRC-5 ®broblasts were susceptible to an inhibition in DNA synthesis by infection with control virus alone, which was augmented by expression of exogenous CKIs. These data indicate that all the dierent CKIs are functional in cells from various tissues including breast, lung, and ovary, despite tissue speci®c expression of some of the endogenous CKIs (Sherr, 1996) . However, in human papillomavirus (HPV)-18 positive HeLa cells, the eect on DNA synthesis of all of the CKIs except p27 was less pronounced. In these cells, the endogenous pRb is sequestered by the HPV-E7 protein (Chellappan et al., 1992) , and thus the expression of CKIs would be expected to have only modest eects. The reduction in DNA synthesis observed following infection with Ad vectors encoding CKIs suggests that not all pRb is inactivated by HPV-E7 within these cells, or the CKIs are inhibiting another cell cycle regulator, perhaps an Rb-family member such as p130 or p107. Moreover, the SAOS-2 cell line expresses a truncated pRb that is defective for E2F-binding and cell cycle regulation (Shew et al., 1990) . In Rb-null SAOS-2 cells none of the CKIs had any eect on DNA synthesis, as would be expected if the CKIs were acting to inhibit pRb phosphorylation.
In comparison to the other CKIs, AdMH4p27 was the most eective in inhibiting DNA synthesis in ®ve of the cell lines examined, including HeLa cells, followed by AdMH4p16 which also eciently induced inhibition of DNA synthesis in most of the lines tested. The eects of vector driven p53 expression on DNA synthesis were most dependent on the cell line studied. For example, at 2 days post-infection, exogenous p53 had no eect on either DNA synthesis or endogenous p21 levels in MT1A2 cells (Figures 3 and 1b) , whereas in SKOV-3 cells, which lack endogenous p53, the inhibition of DNA synthesis approached 100%, consistent with results reported previously with this vector (Bacchetti and Graham, 1993) . In HeLa, MRC-5 and A549 cells which express similar levels of p21 protein with and without exogenous p53 expression (Figure 1b ), transduction with Adp53wt had only a modest eect on DNA synthesis.
CKIs induce a permanent block in cell growth
To determine whether cells infected with Ad vectors directing CKI expression were permanently blocked in cell cycle progression, viable cells were reseeded at low densities 4 days post infection to measure colony forming ability. As demonstrated previously (Figure 2 ), CKI-Ad vector transduced A549 and MT1A2 cells showed reduced viability compared with control-virus infected cells on day 4 post infection (Table 2) . In this experiment, the p16, p18 and p27 vectors induced the greatest amount of cell death, as indicated by Trypan blue staining. The ability of both cell types to form colonies was reduced at least 100-fold after infection with the vectors expressing the CKIs, whereas Adp53 reduced the plating eciency only 3 ± 8-fold. This reduction in colony forming ability suggests that the CKIs can induce permanent growth arrest in transduced human and murine cells.
Ad vector expression of CKIs inhibits the phosphorylation of pRb and alters cell cycle distribution pro®les
The phosphorylation status of pRb is thought to play a key role in the regulation of cell cycle progression (reviewed in Weinbert, 1995) . When present in the hypophosphorylated state, pRb acts to inhibit cell cycle progression, but upon phosporylation by G1 cyclins, pRb is rendered functionally inactive and releases transciption factor E2F which is essential for cell cycle advance. The CKIs have been proposed to block the cell cycle by inhibiting the phosphorylation and inactivation of pRb (Sherr, 1996) . Since hypo-and hyperphosphorylated pRb are readily distinguished on SDS-
polyacrylamide gels, to demonstrate that the expression of CKIs inhibited the phosphorylation of pRb, MT1A2 and A549 cells were infected with the various Ad vectors and after 48 h, cell lysates were prepared and the Rb status analysed by Western blotting. Both hyper-and hypo-phosphorylated pRb were observed in mock-and control-virus infected A549 and MT1A2 cells (Figure 4a and b). But, in lysates prepared from both A549 and MT1A2 cells infected with the dierent CKIs, hypophosphorylated pRb was the prominent species con®rming that the CKIs were inhibiting the phosphorylation of pRb. Hyperphosphorylated pRb was not observed in A549 cells infected with the CKI vectors, whereas in MT1A2 cells, some hyperphorphorylated pRb was detected in lysates prepared from AdMH4p16, AdMH4p18, AdMH4p19 and AdMH4p21-infected cells. These results are consistent with our data on the inhibition of cell growth by over-expression of CKIs within these cell lines (Figure 2 ). Inhibition of both cell growth and pRb phosphorylation were greater in A549 cells compared to MT1A2 cells. Moreover, p16 and p27 were the most eective at blocking pRb phosphorylation and inhibiting DNA synthesis ( Figure 3 ). As protein from equivalent cell numbers was loaded on each lane, it appears that there may be a reduction in cellular levels of pRb within A549 cells following cell cycle arrest, as the amount of pRb decreases following CKI expression. To see if the CKIs diered in their ability to induce G0/G1 versus G2 arrest, cell cycle analysis was performed on transduced A549 and MT1A2 cells. Two days post-infection, A549 cells expressing exogenous p16, p18, p19, p21 and p27 showed an accumulation of cells in G0/G1 compared to mockand control-virus infected cells ( Figure 4c ) consistent with CKIs inhibiting phosphorylation of pRb ( Figure  4a ) thus inducing G1 arrest. However, with MT1A2 cells, the cell cycle pro®les of cells expressing the CKIs diered. MT1A2 cells infected with AdMH4p16 and AdMH4p27, which produced the greatest inhibition of pRb phosphorylation (Figure 4b ), showed an enrichment of cells in G0/G1 compared to mock-and control virus infected cells. In MT1A2 cells expressing exogenous p18 and p19, and to a lesser extent, p21, cells accumulated in G2/M (Figure 4d ). These vectors were also less eective at inhibiting pRb phosphorylation in transduced MT1A2 cells (Figure 4b) . Thus, the ability to arrest cells in G0/G1 correlates with the ability of the CKIs to inhibit pRb phosphorylation. 
Induction of apoptosis in cells transduced with vectors expressing CKIs
Since by day four, a signi®cant proportion of both MT1A2 and A549 cells transduced with the vectors expressing the CKIs p16, p18 and p27 stained positive with Trypan blue, indicative of cell death (Table 2) , we attempted to ascertain whether these vectors were inducing apoptosis. To con®rm that apoptosis had occurred in A549 cells transduced with Ad vectors Figure 4 Phorphorylation status of pRb and cell cycle analysis of cells infected with Ad vectors expressing CKIs. A549 (a) or MT1A2 (b) cells were mock (m), AdBHGD1,3 (c), AdMH4p16 (p16), AdMH4p18 (p18), AdMH4p19 (p19), AdMH4p21 (p21), or AdMH4p27 (p27)-infected at a m.o.i. of 100. Cell lysates were prepared 2 days later, and protein from equivalent cell numbers was analysed by SDS ± PAGE and Western blotting as described under Materials and methods, probing with a monoclonal anti-human pRb antibody (Pharmingen). Arrows denote pRb, with asterisk denoting hyperphosphorylated pRb. For cell cycle analysis, A549 (c) or MT1A2 (d) cells were untreated (mock) or AdBHGD1,3, AdMH4p16, AdMH4p18, AdMH4p19, AdMH4p21, AdMH4p27, or Adp53wt-infected at a m.o.i of 100 for 48 h, after which cells were harvested by trypsinization, stained with propidium iodide staining solution and analysed for DNA content as described under Materials and methods expressing p16, p18 and p27, cellular extracts were prepared 3 days post-infection and examined for evidence of poly(ADP-ribose) polymerase (PARP) cleavage. PARP is a 116 kD nuclear protein which in apoptotic cells becomes cleaved by members of the CED-3/ICE family resulting in an 85 kD fragment (Kaufmann et al., 1993; Tewari et al., 1995) . Results are shown in Figure 5a . 116 kD PARP was detected in lysates from mock infected A549 cells and cells infected with control virus or the CKI-expressing viruses. However, the 85 kD cleavage product was only observed in lysates from A549 cells expressing p16, p18 and p27, con®rming that these cells were in fact undergoing an apoptotic response. To control for protein loading, the blot was re-probed with an antibody against actin. PARP cleavage was also examined in transduced HeLa cells. No cleavage products were detected in any of the cell lysates prepared 2 days post-infection, but after 3 days, the 85 kD cleaved form of PARP was clearly present in HeLa cells expressing exogenous p16, p18 and p27 (Figure 5b ). The 3 day delay in the appearance of an apoptotic response in these cells over-expressing p16, p18 and p27 suggests that the role these proteins play in inducing cell death may be more indirect. Trace amounts of cleaved PARP were also detected in mockand control virus-infected, and p19, p21 and p53-expressing HeLa cell lysates. HeLa cells expressing CKIs continue to divide, and this background PARP cleavage may be due to cell death as the monolayer culture achieves con¯uency. The anti-PARP antibody used did not recognize PARP present in mouse MT1A2 cells and thus we were unable to con®rm apoptosis within these cells. However, PARP cleavage was examined in the pRb-null SAOS-2 cell line. SAOS-2 cells were infected at a m.o.i. of 100, and cell lysates prepared 3 days post-infection. A 116 kD band corresponding to PARP was readily detected in lysates from SAOS-2 cells expressing the dierent CKIs, but no cleavage products were detected even in lysates from SAOS-2 cells infected with the p16, p18 and p27-expressing vectors (Figure 5c ), indicating that the pRbdefective SAOS-2 cells were resistant to CKI-induced cell death.
We also examined transduced HeLa cells for apoptotic death by TUNEL staining and¯ow cytometric analysis (Sgonc et al., 1994) . The TUNEL reaction measures terminal transferase incorporation of¯uorescein-12-dUTP into fragmented DNA, a characteristic feature of apoptosis. Figure 6 shows the results from HeLa cells infected for 4 days with the various Ad vectors. For each cell population, thē uorescence observed following the TUNEL reaction is shown against the background¯uorescence in which the labelling reaction was carried out in the absence of terminal transferase. The three Ad vectors expressing p16, p18 and p27, gave a pronounced shift in uorescence intensity following TUNEL staining, indicative of DNA fragmentation resulting from apoptosis. However, for the Ad vectors expressing human p19 and p21 proteins, the dierences in uorescence intensity in reactions carried out in the presence and absence of enzyme were minimal, as was expected since high levels of PARP cleavage were not observed with these cells (Figure 5b ), con®rming that these populations of cells were not undergoing apoptosis. For the p53-expressing vector, there was a modest shift in¯uorescence intensity in the terminal transferase reaction, although not nearly as pronounced as the shifts observed with the vectors expressing p16, p18 and p27. The mock-and control-virus infected cells showed a minor shift in¯uorescence intensity when the labelling reaction was carried out in the presence of terminal transferase indicating a small amount of background labelling. Attempts to measure apoptotic death in A549 and MT1A2 cells by TUNEL assay were unsuccessful as infection with all of the vectors expressing CKIs resulted in a 1 ± 2 log-fold increase in the¯uorescence of the cells compared to uninfected and control virus-infected cells prior to TUNEL labelling masking any shifts in¯uorescence intensity from positive TUNEL staining (data not shown). , AdMH4p16 (p16), AdMH4p18 (p18), AdMH4p19 (p19), AdMH4p21 (p21), AdMH4p27 (p27), or Adp53wt (p53) -infected at a m.o.i. of 100. Cell lysates were prepared 2 (HeLa) or 3 days later (A549, HeLa, SAOS-2) as indicated, and protein from equivalent cell numbers was analysed by SDS ± PAGE and Western blotting as described under Materials and methods, probing with a monoclonal anti-human PARP antibody (Pharmingen). Arrows denote PARP, with an asterisk denoting the 85 kD cleaved form of PARP. A faint, unidenti®ed, cross-reacting band of approximately 95 kD can also be observed in lanes from all lysates prepared from A549 cells. As a control for protein levels, blots were reprobed for actin levels using a mouse monoclonal anti-actin IgM antibody (Calbiochem)
Modulation of tumorigenicity by the CKIs
To study the eects of Ad vectors expressing CKIs on tumorigenicity of PyMidT tumour cells, mammary adenocarcinoma cells were explanted from PyMidT transgenic mice and infected in vitro with either control virus or the CKI expressing viruses. The MT1A2 cell line was derived from these explanted PyMidT mammary adenocarcinoma cells (Addison et al., 1997) , but MT1A2 cells are less tumorigenic than primary PyMidT cells. After a 24 h incubation of infected primary PyMidT cells to allow expression of the transgenes, syngeneic mice were injected s.c. with 5610 5 viable infected tumour cells and monitored for tumour development. There was a slight delay in the onset of tumour formation with cells infected with control virus, AdBHGD1,3 compared with that of mock infected PyMidT cells: when mice were injected with mock infected cells, all of them developed visible tumours by 3 weeks post infection, whereas it took 5 weeks for 100% of mice injected with AdBHGD1,3-infected cells to develop palpable tumours (Figure 7) . However, the delay in tumour formation was much more dramatic following injection with cells expressing the CKIs. The Ad vector expressing human p27 protein was the most eective at inhibiting tumorigenicity in that only one mouse developed a tumour, and that was 22 weeks post injection. After 25 weeks, 3/5 of the mice injected with PyMidT cells expressing p16 were tumour free, compared with 2/5 and 1/5 of mice injected with cells infected with the p18 and p21-expressing vectors, respectively. Human p19 protein was the least eective at inhibiting tumour formation. By 12 weeks, all of the mice injected with cells treated with the p19-expressing vector had developed tumours, although this was still a pronounced delay in the onset of tumour formation relative to the controls. These results are in agreement with our previous data in that the p27 and p16 vectors were the most eective at inhibiting both tumorigenicity and colony forming ability. For PyMidT cells treated with the Ad vectors expressing the p16, p18 and p27 proteins, it would be expected that a signi®cant proportion of the cells underwent cell death, perhaps apoptotis, which could account for the decrease in tumorigenicity. The p19 and p21 vectors had the least eect on tumorigenicity and also had the least eect on viability of PyMidT transformed cells in vitro (Table 2) , although their eect on cell division (Figure 2b ) and colony forming ability (Table 2) suggests that their shut-o of cell cycle progression is fairly permanent. We are uncertain whether the tumours that were observed developed from cells that no longer expressed the transgene or, alternatively, arose from a small subfraction of cells that were inititially uninfected and over time grew out to form tumours.
The Ad vector expressing p16 induces a delay in tumour growth progression
We also tested the ability of the various Ad vectors to induce a delay in tumour progression in vivo, following direct intra-tumoural injection. The tumours (25 ± 35 mm 3 ) were injected with 10 9 plaque forming units Animals were subsequently monitored to follow tumour progression. Neither injection of control virus nor any of the cyclin kinase inhibitor expressing viruses was able to completely block tumour progression (Figure 8 ). Intratumoural injection with AdBHGD1,3 resulted in a slight inhibition of tumour growth compared to phosphate buered saline (PBS) controls, as reported previously (Addison et al., 1997) , possibly as a result of an anti-adenovirus immune response generated against infected cells. There was no signi®cant dierence in the delay of tumour progression observed between tumours injected with control virus versus the Ads expressing the various CKIs p18, p19, p21 and p27. However, injection with AdMH4p16 did result in a modest delay in tumour progression of 10 ± 14 days (Figure 8 ). When the experiment was repeated, similar observations were obtained in that intratumoural injection with AdMH4p16 resulted in a 7 ± 10 day delay in tumour progression compared with control virus. Thus, in vivo, the Ad vector expressing the p16 CKI was eective at inhibiting tumour growth.
Discussion
Gene transfer of CKIs to malignant cells has been proposed as a molecular genetic approach to arrest cancer cell growth . Although gene transfer approaches to deliver p16 and p21 genes have been tried in a number of tumour models (Eastham et al., 1995; Jin et al., 1995; Ohno et al., 1997; , little comprehensive work has been done comparing the ecacies of dierent CKIs. Here we report the use of isogenic Ad vectors encoding CKIs p16, p18, p19, p21 and p27 to examine their eectiveness at inducing growth arrest, inhibiting DNA synthesis, inducing apoptosis, inhibiting tumorigenicity and delaying tumour growth in vivo. All of the Ad vectors expressing the CKIs were eective in vitro in inducing cell cycle arrest in cells expressing functional pRb. As expected, growth of the majority of the transformed and non-transformed cell lines tested was suppressed by the action of the CKIs delivered by Ad vectors, when assayed both by counting cell numbers and by [ 3 H]thymidine incorporation into replicating DNA (Figures 2 and 3) . In contrast, over-expression of the CKIs had no eect on growth of SAOS-2 cells null for pRb, while a modest reduction in [ 3 H]thymidine incorporation was observed in HeLa cells with functionally inactive pRb. Although CKI over-expression did inhibit pRb phosphorylation, the pRb pathway may not be the sole mechanism by which the CKIs exert an antiproliferative eect, and both p21 and p27 have been found to act via pRb independent processes (reviewed in Herwig and Strauss, 1997) . Other pRb family members such as p107 and p130 (reviewed in Mayol and Grana, 1997; Mulligan and Jacks, 1998) , as well as other cell cycle regulators, may play a role in cellular responses to CKI expression.
In A549 cells, the CKIs both inhibited the phosphorylation of pRb and induced an enrichment of cells in the G0/G1 phase of the cell cycle, consistent with the current model in which CKIs act to inhibit G1/S cell cycle advance by preventing the phosphorylation of pRb (Figure 4) . In contrast, MT1A2 cells transduced with vectors expressing p18 and p19, and to a lesser extent the vector expressing p21, showed both an enrichment of cells in G2/M and a weaker ability to inhibit pRb phosphorylation (Figure 4b and d) . Recent studies using both adenovirus vectors and a tetracycline-responsive element to direct transgene expression in a diverse panel of cells report both G0/G1 and G2 arrest with exogenous p21 and p27 expression which may be related to the pRb or the p53 status of the cell (Cayrol et al., 1998; Niculescu et al., 1998; Wang et al., 1997) . As speci®c inhibitors of cyclin D1/CDK4 or CDK6 complexes, p18 and p19 would be predicted to induce G1 arrest, although the eects of overexpressing these CKIs on cell cycle distributions in diering cell lines has not been examined in detail. However, both p18 and p19 mRNA and protein have been found to oscillate during the cell cycle, accumulating during S phase and remaining high throughout G2/M (Hirai et al., 1995) , suggesting that these proteins may play a role during later stages of the cell cycle.
In order for CKI-expressing viral vectors to be eective cancer therapeutic agents, they must be able to induce a permanent arrest in cell cycle advance. Here, we present two lines of evidence suggesting cell cycle arrest induced by the Ad vector driven over-expression of CKIs is permanent. First, the ability to form colonies was signi®cantly impaired when tumour cells transduced with the various CKI-expressing Ad vectors were replated 4 days post-infection (Table 2) . Colony formation decreased 9000-fold for cells expressing p16, 400-fold for cells expressing p27, and 100-fold for cells expressing p19. Second, when explants from primary murine mammary tumours were infected with the CKI- expressing vectors prior to injection in syngeneic mice, tumour formation was signi®cantly delayed and in some cases, tumour formation was completely blocked in a high proportion of animals. Moreover, there was a correlation between the ability to inhibit colony formation and the ability to inhibit tumour formation, since the vector expressing p19 was the least eective at inhibiting both colony formation and tumorigenicity, and vectors expressing p16, p18 and p27 were the most eective.
In addition to growth arrest, some of the CKI Ad vectors were capable of inducing apoptosis in transduced cells. Several reports have demonstrated that high levels of p27 expression induce apoptosis, although the eects of p27 in promoting cell death may be more indirect Wang et al., 1997) . We not only con®rm here that Ad vector driven over-expression of p27 induces apoptosis, but show that two other CKIs, p16 and p18 are capable of inducing apoptosis. Neither of these CKIs has previously been shown to promote apoptosis, although high levels of p16 expression have been shown to render pRb positive carcinoma cells susceptible to apoptotic signals induced by p53 overexpression (Sandig et al., 1997) . It has also been reported that Ad vectors expressing p16 show enhanced cytotoxicity compared to control virus within cell lines expressing functional pRb (Craig et al., 1998) . We also observed that pRb-defective SAOS-2 cells were resistant to CKI-induced cell death since cleavage of PARP was not observed (Figure 6 ) and very few cells stained positive with Trypan blue 4 days post infection (data not shown). While the growth arrest observed by CKI over-expression can be directly related to their ability to inhibit cyclin dependent kinase activity and pRb phosphorylation (Morgan, 1995; Sellers and Kaelin, 1997) , it is unclear if the induction of apoptosis is due to the CKIs in¯uencing the pRb pathway or acting on other, as yet unidenti®ed targets. Although some cell death was observed after 48 h of p16, p18 or p27 over-expression, a further 2 days were required to induce cell death in a majority of the infected cells. This was true not only for A549 ( Figure 5 ) and HeLa cells (Figure 6 ), but also for MT1A2 and SKOV-3 cells in which cell death was measured by Trypan blue staining (Table 2 and data not shown).
The delay in the appearance of apoptotic death in cells expressing high levels of p16, p18 and p27 suggests that the roles these proteins play may be more indirect. In vivo, apoptotic death often is observed in cells undergoing dierentiation processes as they exit the cell cycle (reviewed in Homan and Lieberman, 1994; Liebermann et al., 1995) and CKI expression has been associated with dierentiation (Adachi et al., 1997; Morse et al., 1997; Steinman et al., 1994; Urashima et al., 1997) . Potentially, overexpression of CKIs could induce aberrant differentiation processes with the cellular response to undergo apoptosis. Such a mechanism would account for the delay in death observed with the apoptosis-inducing Ad vectors.
The ability to promote cell death does not appear to be a universal property of all the CKIs in that HeLa and A549 cells expressing high levels p19 or p21 did not undergo apoptosis (Figures 5 and 6) . Moreover, various researchers have reported that p21 promotes cell survival Lu et al., 1998) and, p19 over-expression in myeloid 32D cells not only blocks cell cycle progression, but prolongs cell survival in growth factor starved cells (Adachi et al., 1997) . The fact that each of the CKIs induced growth arrest, but only p16, p18 and p27 induced apoptosis demonstrates that the CKIs vary in their ability to promote or protect against cell death. However, cell death does not appear to correlate with G1 or G2 cell cycle arrest since p16, p18 and p27-expressing A549 and MT1A2 cells all showed appreciable amounts of cell death but varied in the stage of cell cycle arrest.
The ability of the Ad vectors expressing certain CKIs to promote cell death may contribute to their ability to arrest cancer cell growth. Interesting, the three inhibitors, p16, p18 and p27 whose overexpression induced apoptotic death, were most eective at inhibiting primary PyMidT tumour formation. With these vectors, induction of apoptosis as well as cell cycle arrest may account for this loss in tumorigenicity. However, PyMidT cells transduced with the p19 and p21-expressing vectors which had little eect on cell viability in short term assays, also showed a delay in tumour formation thus suggesting that a block in cell cycle advance alone can contribute to the ecacy of these vectors. Exogenous p19 and p27 protein could persist within these cells for long periods of time, or alternatively cell cycle arrest resulting from CKI over-expression could induce transduced cells to undergo terminal dierentiation processes and permanently exit the cell cycle. Tumours that did eventually form might have resulted from a minority of cells that escaped cell cycle arrest following loss of transgene expression, or alternatively arose from a small subfraction of cells that escaped the original infection. It was not unexpected, however, that some tumours would eventually develop as the inhibition of colony forming ability following CKI expression in vitro was not absolute.
When PyMidT tumours were directly injected with Ad vectors expressing CKIs, only the mice injected with the Ad vector expressing p16 showed a moderate delay in tumour growth compared to control mice ( Figure 8 ). As the PyMidT tumour grows fairly well, unless a majority of the cells become transduced, it is not surprising that a growth delay was not observed with the other Ad vectors. These tumours were treated with a single intratumoural injection of virus (10 9 p.f.u.), and previous experience with tumours injected in such a fashion suggests that approximately 10 ± 20% of cells become infected (Addison and Graham, unpublished data) . Other groups have reported the direct injection of Ad vectors encoding the p16 and p21 genes into dierent tumour models. Direct injection of Ad vectors expressing p21 into Renca tumours established in mice resulted in a signi®cant delay in tumour growth, although both a growth delay and even complete tumour regression were observed with control vector alone (Ohno et al., 1997; Yang et al., 1995) . In the PyMidT model, complete and permanent regression of tumours has never been observed in mice injected with control Ad vector. In another study involving a prostate cancer model, a delay in tumour growth but no regression was observed when prostrate tumour cells were injected with an Ad vector expressing p21 (Eastham et al., 1995) and in a nonsmall cell lung carcinoma model, intratumoural injections with a p16-expressing Ad vector was shown to delay tumour growth compared to injection with control virus (Jin et al., 1995) . However, in each of the above cases where tumour growth delay was observed following intratumoural injection with an Ad vector expressing p21 or p16, either repeated injections were performed or a higher dose (10 10 p.f.u.) of virus was used compared to the dose used in this study.
Recently it has been reported that dendritic cells eciently present antigen from apoptotic cells, stimulating class I-restricted CD8 + cytotoxic T lymphocytes (Albert et al., 1998) . Phagocytic engulfment of apoptotic cells in the tumour mass should lead to enhanced antigen presentation and possibly heightened anti-tumour immune responses. Transduction of tumour cells with an apoptosis-inducting vector such as AdMH4p16 could thus result in greater antigen presentation and stimulate anti-tumour immune responses. Such a mechanism would account for the delay in tumour progression observed with AdMH4p16, although dierences in the degree and nature of the apoptotic response may alter the eectiveness of apoptosis-promoting therapies.
When Ad vectors expressing the herpes thymidine kinase suicide gene and murine IL-2 are used in combination, the transgene products have been shown to act synergistically to induce regression of oral cancers in mice, and it was postulated that cell debris resulting from activity of the suicide gene enhanced the IL-2 activated anti-tumour immune response (O'Malley et al., 1996) . In a separate study, combination therapy with Adp53wt, capable of inducing apoptosis within certain cells, and a low viral dose of Ad vector expressing IL-2 was shown to be eective in promoting regressions in 65% of PyMidT tumours without the toxicity observed at higher doses of IL-2 expressing vector (Putzer et al., 1998) . Since AdMH4p16 and AdMH4p27 were eective at promoting apoptosis and inhibiting tumorigenicity following ex vivo transduction, they should be capable of augmenting the anti-tumour immune responses induced by Ad vectors expressing cytokines such as IL-2. We are currently exploring the possibility of using a combination approach to gene therapy with vectors expressing CKIs capable of inducing apoptosis together with cytokines such as IL-2 or IL-12.
Materials and methods
Cell culture
The 293 cell line (human embryonic kidney Ad5E1-transformed) and the MT1A2 cell line (derived from a mammary adenocarcinoma obtained from a PyMidT transgenic mouse) (Addison et al., 1997) were cultured in minimal essential medium (MEM)-F11supplemented with 10% foetal bovine serum (FBS). MRC-5 cells (human ®broblast; ATCC CCL 171), A549 cells (human lung carcinoma; ATCC CCL 185), SKOV-3 cells (p53 negative human ovarian adenocarcinoma obtained from Hal Hirte, McMaster University) and HeLa cells (HPV-18 transformed cervical carcinoma) were maintained in a-MEM plus 10% FBS. SAOS-2 cells (pRb negative human osteocarcinoma, a gift from P Whyte, McMaster University) were grown in Dulbecco's medium supplemented with 10% FBS. All media were supplemented with 2 mM L-glutamine, 100 mg/ml penicillin and 100 U/ml streptomycin. Culture media and supplements were obtained from Gibco BRL. The Ad vector AdBHG10D1,3, containing E1 and E3 deletions, has identical backbone sequences to the constructs generated here but does not contain transgene sequences. Adp53wt and AdCA35lacZ have been described previously (Addison et al., 1997; Bacchetti and Graham, 1993; Bett et al., 1994) .
Viruses were propagated on 293 cells, puri®ed by cesium chloride gradient centrifugation, and titered by standard methods (Hitt et al., 1995) . For cesium chloride banding, viruses were grown in 293N3S suspension cells in Joklik's modi®ed medium with 5% FBS.
Construction of recombinant plasmids and adenoviral vectors
Plasmids were constructed using standard molecular biology techniques (Sambrook et al., 1989) . Human p16 cDNA (pBluescriptSK-p16) was obtained from D Beach (Cold Spring Harbor), pxcp21, pAdcp18 and pAdcp19 were obtained from T. Thompson (Baylor College of Medicine), and pSCZhuwtp27 was a gift from J Roberts (Fred Hutchison Cancer Research Center). The various human cyclin kinase inhibitor cDNAs were subcloned into the shuttle plasmid pMH4 placing them under the control of the MCMV immediate early (IE) promoter and the SV40 polyadenylation signal (Addison et al., 1997) .
To construct pMH4p16, pBluescript SK-p16 was digested with EcoRI and XhoI to yield a 0.8 kb fragment. The complementary oligonucleotides, 5'TCGAGAAGCTTG and 5'GATTCCAAGCTTC were then annealed to the XhoI overhang and the resulting fragment ligated to EcoRI and BamHI digested pMH4. To generate pMH4p18 and PMH4p19, a 1 kb BamHI/EcoRI fragment from pAdcp18 and a 1.2 kb BamHI/EcoRI from pAdcp19 were subcloned into the BamHI/EcoRI sites of pMH4, respectively. To construct pMH4p21, a 0.8 kb BamHI fragment from pxcp21 was subcloned into the BamHI site of PMH4, screening subsequently for the correct orientation. To produce pMH4p27, a 2 kb EcoRI fragment from pSCZhuwtp27 was subcloned into the EcoRI site of pMH4.
Adenovirus vectors encoding the cyclin kinase inhibitors were obtained by homologous recombination with pBHG10 in 293 cells as described previously Hitt et al., 1994) .
Western blot analysis of transgene expression
Cells were infected with the various Ad vectors at a m.o.i. of 100 plaque forming units (p.f.u). per cell, and at various times post infection, monolayers were rinsed with PBS and lysed with SDS ± PAGE loading buer (50 mM Tris-Cl, pH 6.8, 100 mM dithiothreitol, 2% SDS). Mockand AdBHGD1,3-infected cells served as a control. Samples were subjected to SDS ± PAGE and transferred to Immobilon P nylon membranes (Millipore). The membranes were blocked with 5% skim milk, 0.1% Tween-20, and then probed with primary antibody according to manufacturer's instructions, washed in PBS, 0.2% Tween-20 and then reprobed with the appropriate horseradish-peroxidase (h.r.p.) conjugated secondary antibody. After washing, the membranes were developed by ECL chemiluminescence detection reagents (Amersham) according to manufacturer's instructions. To detect p16, rabbit polyclonal anti-human p16 antibody (Clontech) followed by h.r.p.-conjugated anti-rabbit IgG(Fc) (Promega) were used. For p21, p27 and pRb detection, mouse monoclonal antihuman WAF1 (Ab-1, Calbiochem), mouse monoclonal antihuman p27 (Ab-2, Calbiochem) and mouse monoclonal antihuman Rb (Pharmingen) respectively were used, followed by h.r.p.-conjugated mouse IgG (H+L) (Promega). To detect poly(ADP ribose) polymerase, cells were lysed with RIPA buer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0), mouse anti-poly (ADP ribose) monoclonal antibody (Pharmingen) was used followed by h.r.p.-conjugated anti mouse IgG (H+L) (Promega), and to detect actin, mouse monoclonal anti-actin IgM antibody IgM followed by h.r.p.-conjugated goat anti-mouse IgM antibody (Calbiochem) was used.
Metabolic labelling of expressed proteins
To detect Ad-vector driven expression of cyclin kinase inhibitors, 60 mm dishes of 293 cells were infected at a m.o.i. of 100 for 8 h, rinsed with PBS and incubated with 50 mCi 35 S-labelled methionine/ cysteine translabel (ICN Radiochemicals) overnight in methionine free medium supplemented with 2% dialyzed FBS. Cells were lysed in SDS ± PAGE sample buer, subjected to SDS ± PAGE, and the resulting gel was dried and analysed on a Molecular Dynamics phosphorimager. The relative molecular weights of the proteins were determined by including Rainbow prestained protein markers (Amersham).
Cell growth rate determination
Cells were seeded in 60 mm dishes at a low density (approximately 10 5 cells/dish) 24 h before infection with the appropriate Ad vector. Triplicate dishes of each treatment were trypsinized and counted at daily intervals as indicated. Cell viability was determined by Trypan blue exclusion, counting cells on a hemocytometer.
Determination of level of infectivity of transduced cells
Cells were seeded in 60 mm dishes at a low density (10 5 cells/dish) and the next day cells were infected at a m.o.i of 100 with AdCA35lacZ expressing b-galactosidase from the MCMV immediate early promoter. Twenty-four hours later, monolayers were washed once with PBS, ®xed with 0.5 ml of 0.2% glutaraldehyde, 2% paraformaldehyde, 2 mM MgCl 2 in PBS for 5 min, washed, and stained with 5 mM K 4 Fe(CN) 6 , 5 mM K 3 Fe(CN) 6 , 2 mM MgCl 2 , 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside in PBS. Plates were incubated for 4 h at 378C, following which blue cells were scored. cells/60 mm dish) were infected and 48 h later, growth medium was removed and replaced with 1 ml fresh medium containing 10 mCi of [ 3 H]thymidine (speci®c activity 6.7 Ci/mmol, Amersham) and the cells were incubated for a further 2 h at 378C. At the end of the labelling period, monolayers were rinsed twice with PBS and lysed for 3 h in 10 mM Tris pH 7.6, 10 mM EDTA, 0.5% SDS containing 0.5 mg/ ml pronase. Following addition of 10% cold trichloroacetic acid (TCA), the lysates were ®ltered through glass ®bre ®lters. The ®lters were then rinsed with 95% ethanol, dried and processed for liquid scintillation counting. Measurements represent averages of quadruplicate samples.
Determination of colony forming ability of cells transduced with Ad vectors expressing CKIs
Subcon¯uent A549 and MT1A2 cells were infected in triplicate at a m.o.i. of 100. After 4 days, cells were removed with trypsin, washed with PBS and the number of viable cells determined by Trypan blue exclusion. Cells were then reseeded in triplicate serial dilutions at 10 2 ± 10 5 viable cells/10 cm plate and after 14 days, ®xed and stained with crystal violet (Bacchetti and Graham, 1993) . Values represent the number of colonies per 100 cells seeded.
Cell cycle analysis
Cells were plated in 60 mm dishes (2610 5 cells/dish) and infected with Ad vectors at a m.o.i. of 100, as indicated. Two days later, cells were harvested by trypsinization, and resuspended at a concentration of 10 6 cells/ml in PBS, and stained with 50 ml propidium iodide staining solution (0.24 mg/ml propidium iodide, 1% Triton-X 100, 5 mg/ml RNase in PBS) for 15 min. DNA content was measured using a Coulter Epics XL¯ow Center using Epics XL System II software for pro®le analysis.
Flow cytometric analysis of apoptotic cells
Subcon¯uent HeLa cells were infected at a m.o.i. of 100 for 4 days after which cells were harvested for TUNEL staining (Sgonc et al., 1994) . The proportion of cells showing DNA fragmentation was measured by incorporation of¯uorescein isothiocyanate (FITC)-12-dUTP (Boehringer Mannheim) into DNA by using terminal deoxynucleotidyltransferase (TdT; Boehringer Mannheim) and quantitated by¯ow cytometry as described previously (Sgonc et al., 1994) . Brie¯y, cells were washed in PBS containing 1% FBS, ®xed in 2% paraformaldehyde in PBS for 30 min at room temperature, washed once with PBS-1% serum, and permeabilized with 0.1% Triton X-100, 0.1% sodium citrate on ice for 2 min. The permeabilized cells were washed twice with PBS-1% serum, and incubated in TdT reaction mixture (6 mM FITC-12-dUTP, 60 mM dATP, 1 mM CoCl 2 , and 25 U TdT in 30 mM Tris-Cl, pH 7.2 and 140 mM sodium cacodylate). Background auto¯uorescence of cells and non-speci®c uptake of label were measured by reacting the cells in the absence of TdT. Reactions were stopped in 20 mM EDTA, and the cells were subjected to¯ow cytometric analysis on a FACScan (Becton Dickinson), using a 488-nm argon ion laser to excite¯uorescent emissions detected through a 530-nm band pass ®lter. For each sample, 10 000 events were collected.
In vitro infection of tumour cells
The murine PyMidT mammary adenocarcinoma model has been described . Primary tumour cells from PyMidT transgenic mice were prepared as described previously . Cells were cultured overnight at 378C in MEM-F11 with 10% FBS at 10 7 cells per 150 mm dish and infected at a m.o.i. of 100 for 24 h. Cells were removed from the culture dish with trypsin, washed twice in PBS and resuspended in PBS. Viable cells were counted by Trypan blue exclusion. Syngeneic FVB/n mice (Harlan) were anaesthetized with iso¯uorane (Abbot) and injected subcutaneously in the right hind¯ank with 5610 5 viable cells in 200 ml PBS. Mice were then monitored weekly visually and by palpation for the appearance of tumours.
Intratumoural injection with Ad vectors
The PyMidT model was used for tumour studies. After developing visible tumours (approximately 21 days post injection with 10 6 cells), mice were injected intratumourally with 100 ml PBS or with 10 9 p.f.u. Ad vector in PBS. Tumours were measured prior to virus injection and subsequently at twice weekly intervals using calipers. Tumour volume was calculated from the longest diameter and average width, assuming a prolate spheroid shape . Animals were sacri®ced when the longest diameter was greater than 15 mm or when any two measurements were greater than 10 mm.
Abbreviations
Ad, adenovirus; CDK, cyclin dependent kinase; CKI, cyclin dependent kinase inhibitor; h.r.p., horseradish peroxidase; m.o.i., multiplicity of infection; PBS, phosphate buered saline; p.f.u., plaque forming unit; pRb, retinoblastoma protein; PyMidT, polyoma virus middle T antigen.
